IP Library Granted Patent US 9,447,157
Granted Patent B2
US 9,447,157 · App. 14/486,317 · Granted Sep 20, 2016

Nitration shielding peptides and methods of use thereof

Inventors: Stephen M. Black (Martinez, GA); Ruslan Robertovich Rafitov (Evans, GA)
Assignee: Augusta University Research Institute, Inc.
C07K14/47C07K14/4702C07K14/82C12N9/1205C07K2319/00C07K2319/01C07K2319/10C07K2319/21C07K2319/41C07K2319/42C07K2319/43
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,447,157
App. No.
14/486,317
Granted
Sep 20, 2016
Kind
B2
Abstract

Nitration shielding peptides that reduce or prevent nitration of a protein of interest are disclosed. The peptide can serve as molecular sink for nitrating agents, block access of the nitrating agents to the target tyrosine on the protein of interest, serve as substrate for the nitrating agent (i.e., provide an alternative nitratable tyrosine residue), provide a nitrating agent neutralizing moiety such as antioxidant, or a combination thereof. The nitration shielding peptide can be a fusion protein that includes one or more additional domains such a protein transduction domain, a targeting signal, a purification tag, or any combination thereof. Exemplary nitration shielding peptides for reducing nitration of RhoA and PKG-1α, and methods of use thereof for treating pathologies, disease, and disorders associated with nitration of RhoA and PKG-1α, respectively are also provided.

Claims (15)

1. A nitration shielding peptide that reduces or prevents nitration of a protein of interest comprising a nitration shielding domain comprising

SEQ ID NO:20, wherein the nitration shielding peptide has a nitroxide conjugated to at least one amino acid of the nitration shielding peptide and wherein the nitration shielding peptide is 11 to 15 amino acids in length.

2. The nitration shielding peptide of claim 1 wherein the nitration shielding domain is 11 amino acids in length.

3. The nitration shielding peptide of claim 1 , further comprising a protein transduction domain, a targeting signal, a charge neutralizing moiety, or any combination thereof.

4. The nitration shielding peptide of claim 1 , wherein the nitroxide is 3-carboxy-2,2,5,5-tetramethyl-3-pyrrolin-1-yloxy.

5. The composition of claim 1 , wherein the nitroxide is conjugated to the tyrosine of the peptide.

6. A pharmaceutical composition comprising the nitration shielding peptide of claim 1 and a carrier suitable for in vivo administration to a subject.

7. A nitration shielding peptide comprising a nitration shielding domain comprising SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23,

wherein the nitration shielding peptide blocks protein nitration of RhoA,

wherein the nitration shielding peptide is not full-length RhoA, and

wherein the nitration shielding peptide is 9 to 15 amino acids in length and comprises a nitroxide conjugated to at least one amino acid of the nitration shielding peptide.

8. The nitration shielding peptide of claim 7 wherein the nitration shielding domain is 9 amino acids.

9. The composition of claim 7 , wherein the nitroxide is conjugated to the tyrosine of the peptide.

10. A nitration shielding peptide that reduces or prevents nitration of a protein of interest comprising a nitration shielding domain comprising SEQ ID NO:20, wherein the nitration shielding peptide has a nitroxide conjugated to at least one amino acid of the nitration shielding peptide and is 11 amino acid in lengths.

11. A nitration shielding peptide that reduces or prevents nitration of a protein of interest comprising a nitration shielding domain comprising SEQ ID NO: 20, wherein the nitration shielding peptide has a 3-carboxy-2,2,5,5,-tetramethyl-3-pyrrolin-1-yloxy conjugated to at least one amino acid of the nitration shielding peptide.

Assignments (4)
CONFIRMATORY LICENSE Recorded Jan 24, 2018
From: AUGUSTA UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045139/0420 →
CHANGE OF NAME Recorded Apr 20, 2016
From: GEORGIA REGENTS RESEARCH INSTITUTE, INC.
To: AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
Reel/Frame 038476/0282 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2015
From: BLACK, STEPHEN M.; RAFIKOV, RUSLAN ROBERTOVICH
To: GEORGIA REGENTS UNIVERSITY
Reel/Frame 035146/0736 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2015
From: GEORGIA REGENTS UNIVERSITY
To: GEORGIA REGENTS RESEARCH INSTITUTE, INC.
Reel/Frame 035146/0748 →
Continuity (2)
Provisional Application 61877650 · Sep 13, 2013
Related Publication 20150080288A1 · Mar 19, 2015